Rhumbline Advisers Sells 50,284 Shares of Sabra Healthcare REIT, Inc. $SBRA

Rhumbline Advisers lessened its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 5.8% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 824,077 shares of the real estate investment trust’s stock after selling 50,284 shares during the quarter. Rhumbline Advisers owned approximately 0.34% of Sabra Healthcare REIT worth $15,361,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in the company. Cornerstone Wealth Management LLC lifted its stake in shares of Sabra Healthcare REIT by 256.6% in the 3rd quarter. Cornerstone Wealth Management LLC now owns 39,781 shares of the real estate investment trust’s stock valued at $742,000 after purchasing an additional 28,625 shares during the last quarter. AlphaQuest LLC increased its position in shares of Sabra Healthcare REIT by 309.2% during the 3rd quarter. AlphaQuest LLC now owns 144,839 shares of the real estate investment trust’s stock valued at $2,700,000 after purchasing an additional 109,444 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al raised its holdings in Sabra Healthcare REIT by 51.2% during the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 577,800 shares of the real estate investment trust’s stock valued at $10,770,000 after buying an additional 195,600 shares during the period. Franklin Resources Inc. lifted its position in Sabra Healthcare REIT by 27.4% in the second quarter. Franklin Resources Inc. now owns 503,499 shares of the real estate investment trust’s stock worth $9,285,000 after buying an additional 108,268 shares during the last quarter. Finally, Allianz Asset Management GmbH boosted its stake in Sabra Healthcare REIT by 9.9% during the third quarter. Allianz Asset Management GmbH now owns 902,998 shares of the real estate investment trust’s stock worth $16,832,000 after buying an additional 81,293 shares during the period. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on SBRA shares. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Cantor Fitzgerald raised their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Tuesday. Jefferies Financial Group reaffirmed a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. Finally, Truist Financial increased their price target on Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “hold” rating in a report on Tuesday, January 20th. Five equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $21.60.

Sabra Healthcare REIT Price Performance

Sabra Healthcare REIT stock opened at $20.03 on Thursday. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.29 and a quick ratio of 4.29. The stock has a market cap of $5.05 billion, a price-to-earnings ratio of 31.30, a price-to-earnings-growth ratio of 1.45 and a beta of 0.67. The firm has a 50-day moving average of $19.10 and a two-hundred day moving average of $18.81. Sabra Healthcare REIT, Inc. has a 1 year low of $15.60 and a 1 year high of $20.70.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The company had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. During the same period in the prior year, the firm posted $0.36 EPS. The business’s revenue was up 16.2% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be issued a $0.30 dividend. The ex-dividend date is Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s payout ratio is currently 187.50%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.